To ensure maximum safety, MarketsandMarkets has initiated a mandatory COVID-19 vaccination policy for all in-person attendees across all our physical events. Attendees will be asked to provide proof of vaccination. Additional details on the vaccine policy will be provided upon registration.

Attendees that cannot participate due to this policy, or because of any travel restrictions, are encouraged to participate in the event by registering virtually and attending the event which will be live streamed on our very well appreciated virtual event platform!

These policies may shift as the virus subsides, but we firmly feel this is the right time for MarketsandMarkets to reopen our much awaited physical events safely! We stay committed in our fight against COVID, a variety of new protocols and elevated practices are in place at the venue along with maintaining high standards of cleanliness. We are strictly adhering to the safety guidelines outlined by the Government. We also encourage our participants to review all federal, state, and local permitted traveler guidance before travel and making a reservation.

The next step towards changing treatment paradigms in immuno-oncology

The current revolution in immuno-oncology is being driven by Antibody Drug Conjugates, Immune Checkpoint Inhibitors, Bispecific Antibodies and Cell Therapies. Clinical trials have showed that cancer patients can tolerate this immune-based treatment more effectively than conventional treatments like chemotherapy and radiotherapy. It’s clearly one of the hottest fields of Biopharma which has gained momentum in the past few years.

With more than 45 speakers across the world from pharma, bio-pharma and biotech companies, the congress will discuss the latest updates in development of ADC’s, Monoclonal Antibodies, Bispecific Antibodies, Immune Checkpoint Inhibitors and Cellular Therapy

Meet and network with experts from leading universities and industry sharing their knowledge on Preclinical and Translational Immuno-Oncology Developments, Next Gen CAR-T Cell Therapy, Immune Checkpoint Inhibitors, Monoclonal and Bispecific Antibodies and more.

A platform to meet experts from Pharma, bio-pharma and biotech companies and increase your learning in Monoclonal and Bispecific Antibodies, Cell Therapy and Immune Checkpoint Inhibitors.

After our successful edition last year, we are coming up with the “2nd Annual MarketsandMarkets Next-Gen Immuno-Oncology Congress” on 19-20 September, Philadelphia, USA which will gather academicians, researchers and scientists from research institutes pharmaceutical, bio-pharmaceutical and biotechnology companies to discuss the latest updates in development of ADC’s, Monoclonal Antibodies, Bispecific Antibodies, Immune Checkpoint Inhibitors and Cellular Therapy.